4.0 Article

Analyses of registry data of patients with anti-GBM and antineutrophil cytoplasmatic antibody-associated (ANCA) vasculitis treated with or without therapeutic apheresis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Transplantation

Plasma exchange in ANCA-associated vasculitis: the pro position

Andreas Kronbichler et al.

Summary: The PEXIVAS trial found that routine administration of PLEX does not significantly reduce the rate of end-stage kidney disease or death in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis. However, there is a potential for better outcomes in patients with alveolar haemorrhage receiving PLEX treatment.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)

Article Transplantation

Plasma exchange for the management of ANCA-associated vasculitis: the con position

Ulrich Specks et al.

Summary: Advances in the diagnosis and treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis have led to improved survival rates over the last four decades, but the most severe manifestations of the disease are still associated with high mortality and risk of end-stage kidney disease.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)

Article Medicine, General & Internal

Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis

Michael Walsh et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Editorial Material Urology & Nephrology

The Fate of Plasma Exchange and Glucocorticoid Dosing in ANCA-Associated Vasculitis After PEXIVAS

Frank B. Cortazar et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2020)

Article Medicine, General & Internal

Association of Cigarette Smoking With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

Greg McDermott et al.

JAMA INTERNAL MEDICINE (2020)

Article Urology & Nephrology

Developments in the Histopathological Classification of ANCA-Associated Glomerulonephritis

Emma E. van Daalen et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)

Editorial Material Hematology

Update to the ASFA guidelines on the use of therapeutic apheresis in ANCA-associated vasculitis

Rasheed A. Balogun et al.

JOURNAL OF CLINICAL APHERESIS (2020)

Article Urology & Nephrology

ANCA Glomerulonephritis and Vasculitis

J. Charles Jennette et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)

Review Hematology

Adverse events in apheresis: An update of the WAA registry data

M. Mortzell Henriksson et al.

TRANSFUSION AND APHERESIS SCIENCE (2016)

Article Multidisciplinary Sciences

ANCA-Associated Glomerulonephritis: Risk Factors for Renal Relapse

Arda Goceroglu et al.

PLOS ONE (2016)

Article Multidisciplinary Sciences

Farm Exposure as a Differential Risk Factor in ANCA-Associated Vasculitis

P. Willeke et al.

PLOS ONE (2015)

Article Urology & Nephrology

Long-Term Follow-Up of Cyclophosphamide Compared with Azathioprine for Initial Maintenance Therapy in ANCA-Associated Vasculitis

Michael Walsh et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)

Review Rheumatology

Key advances in the clinical approach to ANCA-associated vasculitis

Cees G. M. Kallenberg

NATURE REVIEWS RHEUMATOLOGY (2014)

Article Medicine, General & Internal

Genetically Distinct Subsets within ANCA-Associated Vasculitis

Paul A. Lyons et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Urology & Nephrology

Randomized trial of plasma exchange or high-dosage Methylprednisolone as adjunctive therapy for severe renal vasculitis

David R. W. Jayne et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)

Article Medicine, General & Internal

A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies

D Jayne et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

Article Hematology

Adverse events and problems in therapeutic hemapheresis.: A report from the Swedish registry

R Norda et al.

TRANSFUSION AND APHERESIS SCIENCE (2001)